Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

(2018) Elizabeth A Thiele et al.   LANCET

Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome

(2018) Orrin Devinsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term retention rates for antiepileptic drugs: A review of long-term extension studies and comparison with brivaracetam

(2017) Manuel Toledo et al.   EPILEPSY RESEARCH

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

(2017) Orrin Devinsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome

(2017) Joshua S. Kaplan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Expert Opinion on the Management of Lennox–Gastaut Syndrome: Treatment Algorithms and Practical Considerations

(2017) J. Helen Cross et al.   Frontiers in Neurology

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

(2016) Orrin Devinsky et al.   LANCET NEUROLOGY

Long-term prognosis of patients with Lennox–Gastaut syndrome in recent decades

(2015) Hyo Jeong Kim et al.   EPILEPSY RESEARCH

Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial

(2015) Wendy Waldman Zadeh et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years

(2014) Joan A. Conry et al.   EPILEPSIA

Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

(2014) Orrin Devinsky et al.   EPILEPSIA

Determining minimally important change thresholds for the Seizure Severity Questionnaire (SSQ)

(2013) Joyce A. Cramer et al.   EPILEPSY & BEHAVIOR

Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures

(2012) Nicholas A. Jones et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome

(2011) Y. T. Ng et al.   NEUROLOGY

Childhood Epileptic Encephalopathy with Diffuse Slow Spike-Waves (otherwise known as “Petit Mal Variant”) or Lennox Syndrome

(2010) H. GASTAUT et al.   EPILEPSIA

Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo

(2009) N. A. Jones et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Clobazam in the treatment of Lennox-Gastaut syndrome

(2008) Joan A. Conry et al.   EPILEPSIA